Comparing dye-guided lymph node removal versus standard method in esophageal cancer surgery
Part of Cancer, Digestive system clinical trials.
This study compares two ways of finding and removing lymph nodes during esophageal cancer surgery. One uses a special dye (indocyanine green) to highlight lymph nodes, and the other is the standard method. The goal is to see if the dye method is as effective as the standard method while possibly being less invasive.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 75 years old.
- You have been diagnosed with esophageal squamous cell carcinoma or adenocarcinoma that has not spread to lymph nodes or distant organs.
- You have not received any prior treatment for esophageal cancer (such as chemotherapy, radiation, or immunotherapy).
- You are scheduled for minimally invasive removal of your esophagus and nearby lymph nodes.
- You are in good health, with adequate heart, liver, and kidney function.
- You have not had prior surgery on your esophagus or stomach.
- You are not allergic to iodine or indocyanine green.
- You do not have another cancer requiring treatment.
- You are not pregnant or breastfeeding.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if a special dye called indocyanine green can help surgeons find sentinel lymph nodes during surgery for esophageal cancer. It may help doctors know which lymph nodes to remove for better staging.
This trial tests if a special dye (ICG) and a near-infrared camera can help surgeons see and protect a nerve that controls your voice box during minimally invasive esophagus cancer surgery. The goal is to reduce voice changes after surgery.
This trial uses a green dye to help surgeons see and remove lymph nodes during keyhole surgery for stomach cancer. The goal is to improve the accuracy of lymph node removal.
This trial looks at a minimally invasive surgery approach for people with colon adenocarcinoma that has not spread to lymph nodes or other organs. The team will use special mapping tests on the sentinel lymph node to better understand the cancer spread and help guide treatment decisions.
This study tests whether using a green dye called indocyanine green during minimally invasive esophageal cancer surgery can help the surgeon see blood flow better and improve the healing of the new connection between the esophagus and stomach. It may reduce the risk of leaks after surgery.
This trial tests using a green dye called ICG (indocyanine green) during breast cancer surgery to find the first lymph nodes (sentinel nodes) that cancer may have spread to. It aims to help doctors locate these nodes more accurately, and is for people with early-stage breast cancer that has not yet spread to the lymph nodes.
Hear when a new Esophageal Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.